Back to search

University of British Columbia

Potential chemical inhibitors of inflammasomes modulate microglial and astrocytic functions

Abstract

dc:description

Alzheimer’s disease (AD) is the sixth leading cause of death worldwide and is characterized by chronic neuroinflammation. Microglia are the brain immunocytes, which normally support and protect neurons; however, they can become adversely activated contributing to onset and progression of neuroinflammation. In addition, defective phagocytic activity of microglia has been suggested to contribute to AD pathogenesis. Astrocytes maintain brain homeostasis but can also become adversely activated leading to the production of excessive pro-inflammatory cytokines and alteration of astrocytic phagocytic activity. Nucleotide-binding domain leucine-rich repeat and pyrin domain-containing receptor (NLRP) 3 inflammasomes are intracellular protein complexes responsible for the activation and production of pro-inflammatory cytokines by immune cells, including microglia and astrocytes. The inflammasome inhibitors, MCC950, shikonin, and oridonin, have previously been shown to suppress inflammasome activation through several different mechanisms and reduce inflammatory activity of peripheral immune cells; however, the full spectrum of the effects of these drugs on the brain cells is still unknown. I hypothesized that MCC950, shikonin, and oridonin regulate a broad range of immune responses by microglia and astrocytes. Therefore, I studied the effects of these inflammasome inhibitors on murine and human microglia-like cells and human astrocytic cell lines that were challenged with established immune stimulants to induce pro-inflammatory responses. MCC950, shikonin, and oridonin decreased the secretion of nitric oxide and glutamate by murine microglia-like cells; however, none of the inflammasome inhibitors had a significant effect on their secretion of interleukin (IL)-1β or tumor necrosis factor-α (TNF). In human microglia-like cells, MCC950 significantly reduced the secretion of IL-1β, but not TNF, while shikonin and oridonin did not influence the secretion of either of these cytokines. Shikonin and oridonin reduced overall toxicity of microglia towards neuronal cells. In human astrocyte-like cells, MCC950, shikonin, and oridonin significantly reduced the secretion of IL-1β. Shikonin also significantly reduced the overall toxicity of astrocytes towards neuronal cells. Phagocytic activity of both resting and immune-stimulated microglia and astrocytes was upregulated by the inflammasome inhibitors, further supporting their potential neuroprotective effects. These results indicate that MCC950, shikonin, and oridonin should be investigated further as possible therapeutic agents for targeting neuroinflammation in AD.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Biochemistry and Molecular Biology
Grantor dc:publisher
University of British Columbia
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Greuel, Bridget Kaytie
Contributors dc:contributor
  • Klegeris, Andis

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/84202

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Greuel, Bridget Kaytie. Potential chemical inhibitors of inflammasomes modulate microglial and astrocytic functions. master's thesis, University of British Columbia, 2023. http://hdl.handle.net/2429/84202